Japan Menopause Market Size & Outlook, 2022-2030
Japan menopause market, 2018-2030 (US$M)
Related Markets
Japan menopause market highlights
- The Japan menopause market generated a revenue of USD 909.9 million in 2022 and is expected to reach USD 1,416.8 million by 2030.
- The Japan market is expected to grow at a CAGR of 5.7% from 2023 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
- Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2022 | USD 909.9 million |
| Market revenue in 2030 | USD 1,416.8 million |
| Growth rate | 5.7% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Dietary Supplements |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, Japan accounted for 5.6% of the global menopause market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China menopause market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,632.2 million by 2030.
Dietary supplements was the largest segment with a revenue share of 94.24% in 2022. Horizon Databook has segmented the Japan menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
Researchers in the country are focused on use of ingredients derived from plants and herbs for formulating dietary supplements, considering their safety as compared to synthetic supplements. Results of the clinical trial to check the effect of Pycnogenol, and antioxidant plant extracts, was published in February 2013.
The study, conducted at the Keiju Medical Center in Ishikawa Prefecture, Japan, revealed the efficacy of Pycnogenol, extracted from French maritime pine tree, in reducing the climacteric symptoms in menopausal women. The research initiatives to promote product innovation contribute to the availability of products in the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan menopause market size, by treatment, 2018-2030 (US$M)
Japan Menopause Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
